Study Design: A retrospective study that involved a total of 82 adult deformity patients who underwent spinal fusion surgery with instrumentation of 6 or more levels.
Objective: The purpose of this study is to assess the efficacy and safety of aprotinin in reducing blood loss in adult spinal deformity patients.
Summary Of Background Data: Aprotinin is an antifibrinolytic agent, which has been proven to be effective as a blood-conserving agent in cardiac surgery.